Despite my attempts at balanced posts I tend to agree PROVIDED Mix&Go can actually add value.
That is yet to be proven - we can only hope that either Philips or BioM are playing with M&G right now or that they have given a device to ADO to play around with. I'd prefer the latter as it seems that when ever we put M&G in others hands they muck it up or do something wrong and it delays things as ADO prove it works and then they re-test.
If it doesn't work then it doesn't work but I'd rather our scientists play around with it and be satisfied that it doesn't work then the other way around.
I hope the quarterly expands a little on how close things are or are not - it can be dissapointing but it's time for Geoff to get over the pasting he got for the 'perilously close' comment and draw up one of those beautiful biotech delivery timelines to excite us.
They got the nod from the Board to go on sequential global tours and a string of conferences and it would be great if the shareholders started to get a little more info about the plans and targets - we are in the delivery zone now and a little health pressure on management to deliver the sales is always good.
I've got that feeling in ma bones again so it's time for me to take a little break from HC again - spending too much time on here. Wish me luck in the self control and see you all in a while - hopefully to arrange a drinks venue at the AGM . . .
ADO Price at posting:
7.3¢ Sentiment: LT Buy Disclosure: Held
